独立行政法人 労働者健康安全機構 横浜労災病院は、神奈川県横浜市港北区にある医療機関。独立行政法人労働者健康安全機構が運営する労災病院である。横浜市立大学医学部の関連病院であり、医師の卒後臨床研修指定病院でもある。

During the past decade, Yokohama Rosai Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yokohama Rosai Hospital" are "Cardiovascular Diseases" (1 trials), "Dermatomyositis" (1 trials), "Hypertension" (1 trials), "Pancreatic Pseudocyst" (1 trials) and "Pancreatic Pseudocyst Infection" (1 trials). Many other conditions were trialed in "Yokohama Rosai Hospital" in a lesser frequency.

Most popular intervention types in "Yokohama Rosai Hospital" are "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Androgen-deprivation Therapy (ADT)" (1 trials), "Apalutamide" (1 trials), "Bicalutamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yokohama Rosai Hospital" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Yokohama Rosai Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yokohama Rosai Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Yokohama Rosai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".